Cathlab & Cardiovascular News
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study - Tamez - 2018 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study - Généreux - 2017 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Acute myocardial infarction - The Lancet
Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
The evolution of antiplatelet therapy in cardiovascular disease | Nature Reviews Cardiology
Cangrelor for treatment during percutaneous coronary intervention | Future Cardiology
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
Stent Thrombosis: A Clinical Perspective | JACC: Cardiovascular Interventions
PDF) Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention: Results From CHAMPION PHOENIX
Cangrelor for treatment during percutaneous coronary intervention | Future Cardiology
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
PCI for STEMI - The Cardiology Advisor
Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial. | Request PDF
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Bernardo Cortese M.D. - Page 10 of 22 - Interventional Cardiologist
60145-x.fp.png "INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology")
INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology
Study flow diagram. | Download Scientific Diagram
Cardiovascular Medicine - Current trends in dual antiplatelet therapy: a 2017 update
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study - Tamez - 2018 - Catheterization and Cardiovascular Interventions - Wiley Online Library
TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics – The CHAMPION PHOENIX Trial | tctmd.com
Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent - ScienceDirect
Novel Antiplatelet Therapies for Atherothrombotic Diseases | Arteriosclerosis, Thrombosis, and Vascular Biology
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
